Protective effect of benidipine against sodium azide-induced cell death in cultured neonatal rat cardiac myocytes

Journal of Pharmacological Sciences

Volumn 93, Issue 2, 2003, Pages 163-170

  Inomata, Koji ^a   Tanaka, Hiroyuki ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Benidipine; Calcium antagonist; Cardiac myocyte; Cell death

Indexed keywords

AMLODIPINE; BENIDIPINE; CALCIUM ANTAGONIST; CALCIUM ION; CALPASTATIN; CANDESARTAN; CAPTOPRIL; LACTATE DEHYDROGENASE; NIFEDIPINE; SODIUM AZIDE;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DEATH; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HEART CELL CULTURE; HEART MITOCHONDRION; HEART PROTECTION; IC 50; MEMBRANE POTENTIAL; MUSCLE CELL; NONHUMAN; RAT;

ADENOSINE TRIPHOSPHATE; AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, NEWBORN; BENZIMIDAZOLES; CALCIUM CHANNEL BLOCKERS; CAPTOPRIL; CELL DEATH; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; DIHYDROPYRIDINES; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIALS; MITOCHONDRIA, MUSCLE; MYOCYTES, CARDIAC; NIFEDIPINE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM AZIDE; TETRAZOLES;

EID: 0242636325     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.163     Document Type: Article

References (24)

1. Nayler WG. The role of calcium in the ischemic myocardium. Am J Pathol. 1981;102:262-270.
2. Steenbergen C, Murphy E, Watts JA, London RE. Correlation between cytosolic free calcium, contracture, ATP and irreversible ischemic injury in perfused rat heart. Circ Res. 1990;66:135-146.
3. Chen SJ, Bradley ME, Lee TC. Chemical hypoxia triggers apoptosis of cultured neonatal rat cardiac myocytes: Modulation by calcium-regulated proteases and protein kinases. Mol Cell Biochem. 1998;178:141-149.
4. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149-166.
5. Kitakaze M, Karasawa A, Kobayashi H, Tanaka H, Kuzuya T, Hori M. Benidipine: A new calcium channel blocker with a cardioprotective effect. Cardiovasc Drug Rev. 1999;17:1-15.
6. Tanaka H, Deguchi T. The protective effect of benidipine hydrochloride against hypoxic myocardial injury of cultured mouse fetal heart cells. Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi). 1995;105:161-169 (text in Japanese with English abstract)
7. Tokuno T, Muraki K, Watanabe M, Imaizumi Y. Protective effect of benidipine against the abnormal electrical activity in single ventricular myocytes of the guinea pig under stimulated ischemic conditions and reperfusion. Jpn J Pharmacol. 2000;82:199-209.
8. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J. 1999;341:233-249.
9. Gorza L, Menabo R, Vitadello M, Bergamini CM, Di Lisa F. Cardiomyocyte troponin T immunoreactivity is modified by cross-linking resulting from intercellular calcium overload. Circulation. 1996;93:1896-1904.
10. Atsma DE, Bastiaanse EML, Jerzewski A, Van Der Valk LJ, Van Der Laarse A. Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition. Circ Res. 1995;76:1071-1078.
11. Kositprapa C, Zhang B, Berger S, Canty JM Jr, Lee TC. Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes. Mol Cell Biochem. 2000;214:47-55.
12. Ichas F, Mazet JP. From calcium signaling to cell death: Two conformations for the mitochondrial permeability transition pore: Switching from low- to high-conductance state. Biochim Biophys Acta. 1998;1366:33-50.
13. Di Lisa F, Bernardi P. Mitochondrial function as a determinant of recovery or death in cell response to injury. Mol Cell Biochem. 1998;184:379-391.
14. 2+ overload by metabolic inhibition in guinea pig. Eur J Pharmacol. 1999;385:225-230.
15. Santostasi G, Kutty RK, Bartorelli AL, Yasumoto T, Krishna G. Maitotoxin-induced myocardial cell injury: Calcium accumulation followed by ATP depletion precedes cell death. Toxicol Appl Pharmacol. 1990;102:164-173.
16. Ishii A, Nishida K, Oka T, Nakamizo N. Receptor binding properties of the new calcium antagonist benidipine hydrochloride. Arzneimittelforschung. 1988;38:1677-1680.
17. 3H]benidipine hydrochloride to rat heart membranes. J Cardiovasc Pharmacol. 1993;21:191-196.
18. 3H-PN200-100 binding sites in membranes of rat hearts and brains. Biol Pharm Bull. 1996;19:195-198.
19. Nishiya Y, Sugimoto S. Effects of various antihypertensive drugs on the function of osteoblast. Biol Pharm Bull. 2001;24:628-633.
20. Tsukiyama H, Kikawada R, Osada H, et al. Usefulness and safety of long-term treatment of benidipine in elderly hypertensives. Geriat Med. 1997;35:989-1007.
21. Shinagawa M, Kubo Y, Otsuka K, Ohkawa S, Cornelissen G, Halberg F. Impact of circadian amplitude and chronotherapy: Relevance to prevention and treatment of stroke. Biomed Pharmacother. 2001;55:125-132.
22. Ishii M. Clinical results of the antihypertensive trial of calcium antagonists. Clin Calcium. 1995;5:891-894.
23. Yao K, Sato H, Ina Y, et al. Benidipine inhibits apoptosis during ischemic acute renal failure in rats. J Pharm Pharmacol. 2000;52:561-568.
24. Gao F, Gong B, Christopher TA, Lopez BL, Karasawa A, Ma XL. Anti-apoptotic effect of benidipine, a long-lasting vasodilating calcium antagonist, in ischaemic/reperfused myocardial cells. Br J Pharmacol. 2001;132:869-878.